Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
Crossref DOI link: https://doi.org/10.1186/s12885-015-1041-3
Published Online: 2015-02-06
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Suzuki, Eiji
Kataoka, Tatsuki R
Hirata, Masahiro
Kawaguchi, Kosuke
Nishie, Mariko
Haga, Hironori
Toi, Masakazu
License valid from 2015-02-06